Broadcast Date: 
  • Time: 

Antibody discovery is a time-intensive process that traditionally can take over 12 months to identify a panel of potential candidates. It can also be costly if those candidates are not well-behaved and fail in downstream in vitro and in vivo functionality and efficacy studies. These headaches can be avoided by employing platforms that provide rapid, multiparameter data upstream in the antibody discovery process.

In this GEN webinar, our expert presenters will take us through case studies on CD47, TFR1, and SIRPa antibody discovery programs leveraging the Distributed Bio’s antibody discovery technology. The data from these studies will demonstrate the key platforms that allow you to move rapidly through the antibody candidate discovery process and introduce you to cost-effective, rapid in vitro antibody validation methods to remove troublesome candidates earlier and more cost-effectively.

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists.

charles river logo

Jean-Philippe Burckert
Jean-Philippe Bürckert, PhD
Director of Bioinformatics
Charles River Labs
Kalyani Mondal
Kalyani Mondal, PhD
Associate Director of Biosensors
Charles River Labs